- OptiBiotix Health, a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, has entered into an evaluation agreement with a global dairy company for its SweetBiotix calorie free sweet fibres.

The agreement grants a non-exclusive license for an evaluation period to explore the potential for using the SweetBiotix technology to reduce the sugar content in a range of its dairy food products.

OptiBiotix has previously announced that the five human taste studies on the SweetBiotix product development had created interest from a number of corporates with expertise in the manufacture and commercialisation of speciality ingredients and/or consumer products.

This agreement reflects interest from one of these companies in exploring the use of SweetBiotix in its branded dairy products.

Stephen O'Hara, CEO of OptiBiotix, said: "We are pleased to announce the signing of this agreement for SweetBiotix with one of the world's largest dairy companies and such a well-known global brand.

"This is part of a strategy of working with global partners who have the capability and expertise to manufacture speciality ingredients like SweetBiotix and well-known consumer brands who have the specialist application expertise to incorporate this technology into their own branded breaded, dairy, cereal and beverage consumer products.

"This approach provides a low risk way to fully exploit the wide range of opportunities offered by our SweetBiotix technology."

Story provided by